Roger Jeffs

(Dr. Roger Jeffs Ph.D.)

Currently holds a position at Axsome Therapeutics Inc

Positions

Position Company Period
Lead Independent Director Axsome Therapeutics Inc Jan. 1, 2016 -
Independent Director Dova Pharmaceuticals Inc May 1, 2017 - Nov. 12, 2019
Independent Director Axovant Gene Therapies Ltd Feb. 12, 2018 - Aug. 1, 2019
President, Co-Chief Executive Officer United Therapeutics Corp June 21, 2016 - June 26, 2016
President, Co-Chief Executive Officer, Director United Therapeutics Corp Jan. 1, 2015 - June 21, 2016
Independent Director Axsome Therapeutics Inc Dec. 1, 2014 - Jan. 1, 2016
President, Chief Operating Officer, Director United Therapeutics Corp Jan. 1, 2002 - Jan. 1, 2015
Roger Jeffs's trades of Liquidia Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-16 2025-04-14
US Liquidia Corp (LQDA)
PS Planned sale
14,130 -1.4%
13.57
USD 191,744 		14,130 -1.4% 13.57 USD 191,744
2025-01-14 2025-01-14
US Liquidia Corp (LQDA)
PS Planned sale
22,343 -2.1%
11.78
USD 263,201 		22,343 -2.1% 11.78 USD 263,201
2024-10-15 2024-10-14
US Liquidia Corp (LQDA)
PS Planned sale
8,053 -1.0%
11.11
USD 89,450 		8,053 -1.0% 11.11 USD 89,450
2024-07-15 2024-07-12
US Liquidia Corp (LQDA)
PS Planned sale
8,053 -1.0%
12.53
USD 100,904 		8,053 -1.0% 12.53 USD 100,904
2024-04-16 2024-04-12
US Liquidia Corp (LQDA)
PS Planned sale
8,360 -1.0%
14.58
USD 121,889 		8,360 -1.0% 14.58 USD 121,889
2024-03-19 2024-03-18
US Liquidia Corp (LQDA)
PS Planned sale
28,583 -3.3%
15.82
USD 452,183 		28,583 -3.3% 15.82 USD 452,183
2024-03-15 2024-03-15
PS Planned sale
2,347 -1.9%
71.61
USD 168,062 		2,347 -1.9% 71.61 USD 168,062
2024-03-15 2024-03-14
PS Planned sale
16,976 -12.3%
69.70
USD 1,183,261 		16,976 -12.3% 69.70 USD 1,183,261
2024-03-15 2024-03-14
PS Planned sale
13,000 -9.7%
69.70
USD 906,126 		13,000 -9.7% 69.70 USD 906,126
2023-12-18 2023-12-14
US Liquidia Corp (LQDA)
PP Planned purchase
139,665 +27.9%
7.16
USD 1,000,001 		139,665 +27.9% 7.16 USD 1,000,001
2022-09-07 2022-09-06
US Liquidia Corp (LQDA)
B Purchase
43,820 +37.8%
5.57
USD 243,990 		43,820 +37.8% 5.57 USD 243,990
2022-09-01 2022-08-31
US Liquidia Corp (LQDA)
B Purchase
993 +0.9%
4.90
USD 4,870 		993 +0.9% 4.90 USD 4,870
2022-05-25 2022-05-24
US Liquidia Corp (LQDA)
B Purchase
28,000 +150.6%
3.53
USD 98,812 		28,000 +150.6% 3.53 USD 98,812
2021-11-23 2021-11-19
B Purchase
3,950 +3.4%
37.30
USD 147,350 		3,950 +3.4% 37.30 USD 147,350
2019-07-02 2019-07-01
PS Planned sale
1,308 -1.9%
14.17
USD 18,534 		1,308 -1.9% 14.17 USD 18,534
2004-10-22 2004-10-21
S Sale
3,500 -20.0%
32.05
USD 112,165 		3,500 -20.0% 32.05 USD 112,165
2004-10-07 2004-10-07
S Sale
3,500 -20.0%
33.55
USD 117,425 		3,500 -20.0% 33.55 USD 117,425
2004-07-16 2004-07-15
S Sale
3,500 -20.0%
24.49
USD 85,705 		3,500 -20.0% 24.49 USD 85,705
2004-07-08 2004-07-08
S Sale
3,500 -20.0%
24.73
USD 86,548 		3,500 -20.0% 24.73 USD 86,548
2004-05-20 2004-05-20
S Sale
3,500 -20.0%
22.94
USD 80,290 		3,500 -20.0% 22.94 USD 80,290
2004-05-10 2004-05-06
S Sale
3,500 -20.0%
25.31
USD 88,580 		3,500 -20.0% 25.31 USD 88,580
// ... existing code ... // ... rest of the file ...